R&D Healthcare brands are caught in a data privacy trap The digital advertising industry must adapt or accept the consequences of compliance failures.
Views & Analysis How the EU’s GDPR will be a positive catalyst for change Now that the GDPR deadline of May 25 has come and gone, many life sciences companies will have come to realise that GDPR compliance is not simply a legal problem or an IT project, but an enterprise
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
